20 April 2004
Chondrosarcoma – the second neoplasm in a 16-year-old girl previously treated for Wilms tumor
Katarzyna Sznurkowska, Stefan Popadiuk, Maria Korzon, Mariola RutkowskaCase Rep Clin Pract Rev 2004; 5(null):264-268 :: ID: 12274
Abstract
Background: The incidence of second malignancies seems to be a significant problem, increasing with the progress of oncology. The main factors causing the development of second neoplasms seem to
be chemotherapy and radiotherapy , but the endogenous factors that lead to the first and then second malignancy also play an important role. The most important therapeutic agent that causes second neoplasms is radiotherapy. It was applied in the treatment of almost all patients suffering from second neoplasms after the treatment of Wilms tumor. Second malignancies in the radiation field develop slowly - the average period of their incidence is 12 years.They are usually carcinomas, or bone and soft tissue sarcomas.Case Report: We present the case of a 16-year-old girl, who had undergone treatment of a Wilms tumor in childhood and developed second malignancy in the radiation field.The tumor proliferated in the hip bone infiltrating the vertebral column and inferior vena cava. Although the patient remained under oncological control, the second malignancy was diagnosed at an advanced clinical stage. Effective treatment was impossible because the tumor was inoperable and resistant to chemotherapy.Conclusions: Second malignancies are a rare, but very significant late effect of oncological treatment. Patients who were treated because of malignancies in childhood must be under oncologist’s control throughout the whole life. Patients after radiotherapy in the treatment of Wilms tumor require precise imaging studiesof bones situated in the radiation field.
Keywords: Wilms tumor second malinancy, Chondrosarcoma, children
271
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947099
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946151
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946630
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946954
Most Viewed Current Articles
21 Jun 2024 : Case report
93,594
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
51,205
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
28,023
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
22,997
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030